Cargando…
(99m)Tc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
Triple negative breast cancer (TNBC), the most aggressive breast cancer type, is associated with high mortality and recurrence rates. An active-targeted strategy based on homing peptides is an effective approach to diagnose and treat cancer as it can deliver imaging agents or therapeutic drugs into...
Autores principales: | Song, Ningning, Zhao, Lingzhou, Zhu, Meilin, Zhao, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778934/ https://www.ncbi.nlm.nih.gov/pubmed/31598115 http://dx.doi.org/10.1155/2019/9502712 |
Ejemplares similares
-
Recent progress in LyP-1-based strategies for targeted imaging and therapy
por: Song, Ningning, et al.
Publicado: (2019) -
[(99m)Tc]Tc-Labeled Plectin-Targeting Peptide as a Novel SPECT Probe for Tumor Imaging
por: Gong, Jiali, et al.
Publicado: (2022) -
(99m)Tc-labeled iRGD for single-positron emission computed tomography imaging of triple-negative breast cancer
por: Yu, Buhui, et al.
Publicado: (2022) -
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using (99m)Tc-labeled dendrimer-entrapped gold nanoparticles
por: Xing, Yan, et al.
Publicado: (2018) -
The efficacy of (99m)Tc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
por: Wang, Taisong, et al.
Publicado: (2023)